Decentralized blockchain voting program launches

Latest articles

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

It’s time to reboot longevity and healthy aging

Dr Michael Roizen calls for fundamental societal changes to ensure the benefits of longevity and healthy aging are realised. Later this year, best-selling author Michael...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

Biotech LyGenesis expands its liver regeneration tech

A new peer-reviewed paper demonstrates the success of using fat-associated lymphoid clusters as expandable niches for ectopic liver regeneration. LyGenesis, a clinical-stage biotech developing cell...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Click the globe for translations.

Longevity Science Foundation program will see donors using “LSF Points” to select projects for funding.

The Longevity Science Foundation – a Swiss nonprofit dedicated to advancing the healthy human lifespan – has announced today it will use blockchain technology in its funding selection process. To do so, the foundation has created LSF Points, which will be distributed to all foundation donors. These non-monetary tokens will empower donors to vote on which projects and proposals they believe should be funded by the foundation. All projects under consideration will first be chosen by the LSF Visionary Board for their technical soundness, impact and scientific quality.

Longevity.Technology: Digital tech has exploded over the last decade-and-a-half, or so, and blockchain has been one of the most disruptive elements, causing a radical rethink of how people interact and leverage financial and information services. Due to its independent verficiation processes, blockchain offers enormous levels of security and innovation, something that the LSF will now leverage. The LSF prides itself on its innovative governance approach, granting its donors voting rights and early innovation access opportunities in exchange for their contributions. This inclusive and holistic model for giving that ensures all donors have a say in the Foundation’s direction and funding decisions and organising this process by LSF Points will make it even more equitable.

“Beyond having a credible, strict and transparent evaluation and selection process, the LSF wishes to accommodate a system for donors to also express their opinion and vote for their favourites among the applications,” Visionary Board chairman Evelyne Yehudit Bischof said. “This program will not only encourage donor involvement but will also help us achieve our mission of bringing more longevity-based solutions to a wider audience within the next five years.”

The LSF Points are not an investment instrument and do not possess any monetary value. The LSF does not sell or exchange LSF Points for any currency – they are strictly an instrument for internal decision-making and governance. However, in addition to votes, donors can use points to earn rewards such as NFTs commemorating contributions, consultations with longevity specialists, and early access to treatments. Point transfers and report security will be managed via smart contracts on an Ethereum-based public blockchain.

“We aim to maintain full transparency while reducing bureaucratic burden in the funding process,” Bischof said. “Every funding decision the foundation makes is fully auditable applying the new blockchain program, which guarantees transparency around LSF work.”

After receiving funding proposals, a team of longevity opinion leaders pre-vets and shortlists selected proposals and defines priority vectors to deliver a comprehensive set of funding targets. These are reviewed by donors who then execute their voting rights through their holding of LSF Points. Details of the process can be found on the website.

The foundation is focused on selecting and supporting projects in four major areas of longevity medicine and health tech: predictive diagnostics, therapeutics, personalised medicine and AI. The foundation is seeking to fund projects that can facilitate and accelerate significant progress in longevity medicine as soon as possible.

The Visionary Board is composed of leading longevity researchers such as Bischof, Andrea B Maier, Eric Verdin, Matt Kaeberlein, Michael Levitt and Alex Zhavoronkov.

Photo: vectopicta/Shutterstock
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Sugar-proof your health with the GLYLO weight loss and antiaging supplement

Move your New Year's resolution up a gear with GLYLO, a double-action supplement that can increase weight loss while also slowing aging. Choosing an effective...

Related articles

“World’s first” cultural-matching app for care sector launches

Care receivers can be paired with carer based on religious understanding and culture thanks to AI tech developed during pandemic. A graduate has created what...

NURO embarks on funding round for neurotech communication system

World’s first multimodal neurotech operating system from NURO allows you to communicate using just your brain. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Omecu aims to reduce analysis time and democratise genome data

Spinout company aims to revolutionise the handling of genome data by drastically reducing the time it takes to analyse millions of genetic records. Omecu Ltd,...

Machine learning robots a step in the right direction for tetraplegic patients

Machine learning enables thought-controlled robots that learn from mistakes. Two Ecole Polytechnique Fédérale de Lausanne (EPFL) research groups teamed up to develop a machine learning...

Abbott launches Lingo longevity wearable with continuous ketone tracking

Abbott pushes the envelope of biowearables as it announces its new tech for tracking ketones biomarkers. Abbott, the company behind the Freestyle Libre continuous glucose...

    Subscribe to our newsletter